Crystallography, NMR and virtual screening: integrated tools for drug discovery.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current opinion in drug discovery & development

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 12951817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rational design, synthesis, and verification of affinity ligands to a protein surface cleft

  2003cited by this paper
• Facilities and methods for the high-throughput crystal structural analysis of human proteins.

  2003cited by this paper
• NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors.

  2003cited by this paper
• NMR-based structural characterization of large protein-ligand interactions

  2002cited by this paper
• NMR reporter screening for the detection of high-affinity ligands.

  2002cited by this paper
• Solution NMR techniques for large molecular and supramolecular structures.

  2002cited by this paper
• Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.

  2002cited by this paper
• High-throughput crystallography for lead discovery in drug design

  2002cited by this paper
• Structure-based screening and design in drug discovery.

  2002cited by this paper
• Using X-ray crystallography in drug discovery.

  2002cited by this paper
• Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation.

  2002cited by this paper
• Nmr in drug discovery

  2002cited by this paper
• In silico and NMR identification of inhibitors of the IGF-I and IGF-binding protein-5 interaction.

  2002cited by this paper
• Structure-based screening of low-affinity compounds.

  2002cited by this paper
• The genesis of high-throughput structure-based drug discovery using protein crystallography.

  2002cited by this paper
• NMR and in silico screening.

  2002cited by this paper
• Applications of SHAPES screening in drug discovery.

  2002cited by this paper
• Structure activity relationship by NMR and by computer: a comparative study.

  2002cited by this paper
• Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor.

  2001cited by this paper
• Experimental and computational mapping of the binding surface of a crystalline protein.

  2001cited by this paper
• Design and synthesis of non-peptidic inhibitors for the Syk C-terminal SH2 domain based on structure-based in-silico screening.

  2001cited by this paper
• High-throughput docking for lead generation.

  2001cited by this paper
• Dipolar couplings as a probe of molecular dynamics and structure in solution.

  2001cited by this paper
• Identification of novel inhibitors of urokinase via NMR-based screening.

  2000cited by this paper
• Recent developments in structure-based drug design

  2000cited by this paper
• Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.

  2000cited by this paper
• Automated crystal mounting and data collection for protein crystallography.

  2000cited by this paper
• NMR-based screening in drug discovery

  1999cited by this paper
• The inter-ligand Overhauser effect: A powerful new NMR approach for mapping structural relationships of macromolecular ligands

  1999cited by this paper
• Discovering High-Affinity Ligands for Proteins: SAR by NMR

  1996cited by this paper

• Early-stage structure-based drug discovery for small GTPases by NMR spectroscopy.

  2022cites this paper
• Identification of novel anti-tuberculosis agent: An in silico investigation.

  2021cites this paper
• Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach

  2019cites this paper
• Emerging Computational Methods for the Rational Discovery of Allosteric Drugs

  2016cites this paper
• Structural Biology and Anticancer Drug Design

  2014cites this paper
• Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity.

  2014cites this paper
• Surface reengineering of RPA70N enables cocrystallization with an inhibitor of the replication protein A interaction motif of ATR interacting protein.

  2013cites this paper
• QM/MM refinement and analysis of protein bound retinoic acid

  2012cites this paper
• Biophysical characterization of the bindng of homologous anthraquinone amides to DNA

  2012cites this paper
• Drugging challenging targets using fragment-based approaches.

  2010cites this paper
• Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery*

  2009cites this paper
• Structure-based approaches in the design of GSK-3 selective inhibitors.

  2007cites this paper
• Structure‐based Optimization of MurF Inhibitors

  2006cites this paper
• Universal Screening Methods and Applications of ThermoFluor®

  2006cites this paper
• Crystallization to obtain protein-ligand complexes for structure-aided drug design.

  2006cites this paper
• Finding protein kinase hits using structural information.

  2006cites this paper
• Handbook of Preformulation: Chemical, Biological, and Botanical Drugs

  2006cites this paper
• Drug Discovery Trends

  2006cites this paper
• Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

  2006cites this paper
• Latest development in drug discovery on G protein-coupled receptors.

  2006cites this paper
• Natural products to drugs: natural product derived compounds in clinical trials.

  2005cites this paper
• Structural biology and drug discovery.

  2005cites this paper
• Keynote review: Structural biology and drug discovery

  2005cites this paper
• Compound selection and filtering in library design

  2005cites this paper
• The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.

  2005cites this paper
• Affinity assays for decrypting protein targets of unknown function.

  2005cites this paper
• High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques.

  2004cites this paper
• The role of natural product chemistry in drug discovery.

  2004cites this paper
• Computational chemogenomics approaches to systematic knowledge-based drug discovery.

  2004cites this paper
• High-throughput X-ray crystallography for drug discovery.

  2004influential citation
• Reliable high-throughput functional screening with 3-FABS.

  2004cites this paper
• Using NMR for ligand discovery and optimization.

  2004cites this paper
• Validation of automated docking programs for docking and database screening against RNA drug targets.

  2004cites this paper
• Exploring the active site of human factor Xa protein by NMR screening of small molecule probes.

  2003cites this paper